OmniAb (OABI) Times Interest Earned (2021 - 2026)
OmniAb's (OABI) quarterly Times Interest Earned came in at -$0.35 in Q1 2026, up 76.04% year-on-year from -$0.2 in Q1 2025, and up 97.87% on a QoQ basis from -$16.39 in Q4 2025.
OmniAb (OABI) Times Interest Earned (2021 - 2026) Analysis & Trends
OmniAb (OABI) has 6 years of Times Interest Earned data on file, last reported at -$0.35 in Q1 2026.
- On a quarterly basis, Times Interest Earned rose 76.04% year-over-year to -$0.35 in Q1 2026; TTM through Mar 2026 was -$2.59, a 52.78% increase from a year earlier, with the FY2025 full-year figure at -$3.66, up 72.85% from the prior year.
- Times Interest Earned for Q1 2026 stood at -$0.35, up from -$16.39 in the prior quarter.
- Over the last five years, Times Interest Earned for OABI reached as high as $11.51 in Q4 2023 and fell as low as -$20.14 in Q2 2022.
- Historically, Times Interest Earned has averaged -$4.26 across 5 years, with a median of -$1.4 in 2025.
- Across the five-year window, Times Interest Earned surged 115.64% in 2022 and sank 248.0% in 2024, its largest moves.
- Year by year, Times Interest Earned stood at $10.54 in 2022, then increased by 9.27% to $11.51 in 2023, then plunged by 248.0% to -$17.04 in 2024, then increased by 3.81% to -$16.39 in 2025, then surged by 97.87% to -$0.35 in 2026.
- Per Business Quant data, the three most recent Times Interest Earned figures were -$0.35 in Q1 2026, -$16.39 in Q4 2025, and -$1.4 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | OmniAb | 261.62 Mn | 212.55 Mn | 14.41 Mn | -0.35 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.35 |
| Dec 31, 2025 | -16.39 |
| Sep 30, 2025 | -1.40 |
| Jun 30, 2025 | -0.64 |
| Mar 31, 2025 | -1.46 |
| Dec 31, 2024 | -17.04 |
| Sep 30, 2024 | -1.47 |
| Jun 30, 2024 | -0.57 |
| Mar 31, 2024 | -0.76 |
| Dec 31, 2023 | 11.51 |
| Sep 30, 2023 | -0.65 |
| Jun 30, 2023 | -1.45 |
| Mar 31, 2023 | -0.26 |
| Dec 31, 2022 | 10.54 |
| Sep 30, 2022 | -17.46 |
| Jun 30, 2022 | -20.14 |
| Mar 31, 2022 | -14.35 |
| Dec 31, 2021 | -67.35 |